New Jersey 2024-2025 Regular Session

New Jersey Senate Bill SR29

Introduced
1/9/24  

Caption

Urges health insurance providers and prescription drug providers to offer option of speaking to or leaving message for human.

Impact

If enacted, SR29 would not result in a change to state law, but rather serve as a formal request to health insurance and prescription drug providers to adopt more consumer-friendly communication practices. By advocating for the option to easily connect with a human operator, the resolution addresses significant gaps in consumer rights and accessibility in the health sector. This could lead to improvements in customer satisfaction and potentially streamline resolution of issues faced by policyholders, thus having a positive impact on the overall healthcare experience for many individuals.

Summary

Senate Resolution No. 29 (SR29) is a legislative proposal aimed at urging health insurance providers and prescription drug companies to implement systems that allow individuals to easily speak to or leave a message for a human representative when contacting them. This resolution comes as a response to the growing reliance on automated telephone answering services that can be frustrating and challenging for consumers, particularly for vulnerable populations such as senior citizens and those with disabilities. The push for such a change is driven by concerns over the accessibility and user-friendliness of current automated systems which often hinder effective communication.

Contention

While SR29 is generally likely to receive support for its consumer-oriented approach, debates may arise around the efficiency and cost implications of implementing such changes in communication systems. Stakeholders in the healthcare industry might express concerns regarding the potential financial burden of modifying existing automated services or the feasibility of sustaining enough human operators to handle increased demand. Additionally, some may argue that automating processes can indeed improve operational efficiency despite the challenges encountered by consumers.

Companion Bills

NJ SR44

Carry Over Urges health insurance providers and prescription drug providers to offer option of speaking to or leaving message for human.

Previously Filed As

NJ SR44

Urges health insurance providers and prescription drug providers to offer option of speaking to or leaving message for human.

NJ S208

Allows person calling certain State or local government entities to have option of speaking or leaving a recorded message with a human telephone operator during normal business hours.

NJ S536

Allows person calling certain State or local government entities to have option of speaking or leaving a recorded message with a human telephone operator during normal business hours.

NJ A451

Allows person calling certain State or local government entities to have option of speaking or leaving recorded message with human telephone operator during normal business hours.

NJ A3076

Allows person calling certain State or local government entities to have option of speaking or leaving recorded message with human telephone operator during normal business hours.

NJ SB2031

Health insurance carriers; require to cap patient cost for prescriptions for insulin drugs.

NJ SB2223

Health insurance carriers; require to cap patient cost for prescriptions for insulin drugs.

NJ SB2027

Health insurance carriers; require to cap patient cost for prescriptions for insulin drugs.

NJ SR18

Urges Biden Administration to lift regulatory freeze on executive orders designed to reduce cost of life-saving prescription drugs for Americans.

NJ SR27

Urges Biden Administration to lift regulatory freeze on executive orders designed to reduce cost of life-saving prescription drugs for Americans.

Similar Bills

NJ SR44

Urges health insurance providers and prescription drug providers to offer option of speaking to or leaving message for human.

NJ S4156

Requires Department of Health to provide information to Statewide 2-1-1 telephone system regarding the location of safe disposal sites for hypodermic syringes and needles and prescription drugs.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

NJ A4337

Requires Department of Health to provide information to Statewide 2-1-1 telephone system regarding the location of safe disposal sites for hypodermic syringes and needles and prescription drugs.

NJ A1866

Requires Department of Health to provide information to Statewide 2-1-1 telephone system regarding the location of safe disposal sites for hypodermic syringes and needles and prescription drugs.

NJ S1325

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

NJ S1213

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.

NJ A4545

Prohibits pharmacies from charging additional fee for processing prescriptions transmitted by telephone or electronic means.